0 items USD 0.00Search
Your search for "chronic lymphoma leukemia" gave back 23671 results.
Summary The global Ibrutinib market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and...
Catalog:
HYR
January 2022
Price: USD 1,800.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at US$ 120.9 million in 2023. With growing demand in downstream market,...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - JAK1 is a...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
GIR
April 2023
Price: USD 3,480.00
The global Adult T-Cell Leukemia/Lymphoma Treatment market size was valued at USD 127.2 million in 2023 and is forecast to a readjusted size of USD...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H2 2019 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 Summary According to the recently published report...
Catalog:
Global Markets Direct
March 2021
Price: USD 3,500.00
Tyrosine Protein Kinase JAK1 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
Asia Pacific minimal residual disease (MRD) testing market will grow by 15.5% annually with a total addressable market cap of $4,575.0 million over...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
Europe minimal residual disease (MRD) testing market was valued at $ 265.6 million in 2021 and will grow by 11.8% annually over 2021-2031, driven by...
Catalog:
Grace Market Data
May 2022
Price: USD 2,980.00
